Global AI in Medical Imaging Market - 2025 -2033
AI in Medical Imaging Market Size
The global AI in medical imaging market was valued at US$ 1.29 Billion in 2023. The market size reached US$ 1.58 Billion in 2024 and is expected to reach US$ 11.25 Billion by 2033, growing at a CAGR of 24.6% during the forecast period 2025-2033.
AI in Medical Imaging Market Overview
The AI in medical imaging market is rapidly advancing, fueled by the integration of deep learning algorithms into radiology workflows, enabling faster, more accurate detection of diseases such as cancer, stroke, and neurological disorders. Key drivers include increasing imaging volumes, radiologist shortages, and strong clinical validation of AI tools for triage, segmentation, and diagnosis across modalities like MRI, CT, and PET.
North America leads the market due to early regulatory approvals, robust healthcare IT infrastructure, and high adoption in hospital networks, while Asia-Pacific is the fastest-growing region, driven by aggressive digital health investments in China, Japan, and South Korea, and rising demand for scalable diagnostic solutions.
AI in Medical Imaging Market Dynamics: Drivers & Restraints
Drivers:
Rising demand for early and accurate diagnosis is significantly driving the AI in medical imaging market growth
The growing need for early and precise diagnosis is playing a crucial role in advancing the medical imaging industry, particularly in 2024 and 2025. Conditions such as cancer, stroke, and neurodegenerative diseases demand timely detection to improve treatment outcomes, pushing healthcare providers to seek faster and more accurate imaging technologies. Diagnostic tools are evolving to help clinicians manage increasing caseloads while enhancing image clarity and interpretation accuracy.
For instance, new imaging suites introduced at ECR 2025, including advanced mammography and multi-organ diagnostic platforms, are designed to streamline workflows and improve diagnostic confidence. Innovations like accelerated MRI scanning and enhanced image resolution are also helping reduce patient wait times and improve clinical decision-making.
These developments underscore the healthcare sector’s focus on improving diagnostic efficiency and accuracy to support earlier intervention and better patient outcomes.
The increasing technological advancements are expected to boost the AI in medical imaging market
Technological advancements are fueling a transformative wave in the medical imaging market by enabling significantly faster, higher-quality, and more intelligent diagnostic processes. For instance, in early 2025, Subtle Medical unveiled AI-driven MRI enhancements that accelerate scan time, enable ultra–low-dose imaging, and synthesize missing sequences.
Additionally, in May 2025, Philips, in collaboration with NVIDIA, introduced a “foundation model” for MRI at ISMRM to enhance scan planning, denoising, super-resolution, and interactive image optimization directly in clinical workflows. GE HealthCare and NVIDIA also partnered to develop autonomous X-ray and ultrasound systems, using AI-enhanced robotics to reduce operator dependency and expand diagnostic access.
Cardiovascular diagnostics have also been redefined: Avandra Imaging released an AI-powered MRI platform in 2025, delivering cardiac scan results within minutes, and India’s SGPGIMS began using an AI-enabled intravascular OCT system in May 2025, offering live, high-resolution imaging to guide precision angioplasty. Complementing hardware innovation are software breakthroughs like Viz.ai’s FDA-cleared CT-based tool for automated detection of subdural hemorrhages (June 2025). Together, these advances are reshaping medical imaging to support earlier and more precise diagnoses.
Restraint:
Data privacy and security concerns are hampering the growth of the AI in medical imaging market
Concerns around data privacy and security are anticipated to pose significant challenges to the growth of the medical imaging market, largely due to the sensitive nature of patient health information and the rising vulnerabilities within digital healthcare systems.
Modern imaging technologies often rely on vast amounts of clinical and diagnostic data for analysis, interpretation, and storage. This creates substantial risks related to compliance with strict data protection regulations such as HIPAA in the United States, GDPR in the European Union, and similar laws in other regions. The need to safeguard this information against unauthorized access, breaches, and misuse places a heavy burden on healthcare providers and technology vendors, potentially slowing down the adoption of new imaging solutions and increasing operational costs.
Opportunity:
The expansion into emerging regions is expected to create a lucrative opportunity for the AI in medical imaging market
The development of multimodal AI solutions presents a significant opportunity for the AI in medical imaging market, as it enables a more comprehensive and accurate understanding of patient health by integrating data from multiple sources. Unlike traditional imaging tools that rely solely on visual data, multimodal systems combine various types of inputs to deliver deeper diagnostic insights and personalized care recommendations.
This integrated approach improves diagnostic precision, particularly for complex conditions like cancer, cardiovascular disease, and neurological disorders, where visual findings alone may not be sufficient. For example, combining imaging with blood biomarkers and patient history can help differentiate between benign and malignant tumors more effectively or predict disease progression with higher accuracy.
AI in Medical Imaging Market Segment Analysis
The global AI in medical imaging market is segmented based on modality, deployment mode, component, and region.
The X-ray imaging from the type segment is expected to hold 26.8% of the market share in 2024 in the AI in medical imaging market
X-ray imaging is expected to dominate the AI in medical imaging market due to its widespread use, affordability, and recent technological advancements that have significantly enhanced diagnostic efficiency. As the most commonly performed imaging modality globally, X-rays provide an ideal platform for AI integration, particularly for high-volume screenings such as chest, trauma, and musculoskeletal assessments. Recent developments underscore this trend, including Gleamer’s FDA-cleared ChestView now enables automated detection of lung conditions.
In May 2025, Milvue's TechCare Trauma received FDA clearance for musculoskeletal analysis, and United Imaging’s robotic uAngio AVIVA system introduced AI-enhanced interventional imaging. These advancements, coupled with increasing regulatory approvals and clinical demand, position X-ray imaging as the leading segment driving AI adoption in the medical imaging market.
AI in Medical Imaging Market Geographical Analysis
North America is expected to dominate the global AI in medical imaging market with a 42.6% share in 2024
North America is expected to lead the global AI in medical imaging market in 2025, largely due to early clinical adoption, advanced digital infrastructure, and strong industry-regulatory collaboration. Over 66% of radiology departments in the U.S. are integrating AI tools to streamline workflows, improve diagnostic accuracy, and manage increasing imaging volumes, placing the region well ahead.
This leadership is reinforced by recent launches such as GE HealthCare’s Sonic DL MRI and Philips’ CT 5300, both unveiled at RSNA 2024, which incorporate AI for faster and more precise imaging.
The FDA’s fast-track approvals, alongside initiatives like CIVIE’s RadPod for on-demand diagnostics and Subtle Medical’s AI MRI tools, further highlight the region’s pioneering role. As the chart above illustrates, North America’s aggressive adoption pace positions it as the global benchmark for AI-driven transformation in medical imaging.
Asia-Pacific is growing at the fastest pace in the AI in medical imaging market holding 22.4% of the market share
Asia-Pacific is emerging as the fastest-growing region in the AI-powered medical imaging market, driven by urgent healthcare needs and rapid digital transformation. Robust growth is fueled by a surge in chronic disease prevalence, governmental investment in infrastructure, and supportive state policies, particularly in China and India, which are scaling AI deployments across rural and urban centers.
Innovations such as India’s Telangana-led pilot of AI in cancer screenings and regional generative-AI challenges in ophthalmology underscore a boom in multimodal imaging and screening solutions across Asia-Pacific. These concerted efforts position APAC at the forefront of next-gen, AI-driven diagnostic expansion.
AI in Medical Imaging Market Top Companies
Top companies in the AI in medical imaging market include GE HealthCare, FUJIFILM Corporation, Koninklijke Philips NV, Aidoc, Blackford Analysis, Siemens Healthineers AG, Canon Medical Systems GmbH, Qure.ai, NVIDIA Corporation, SARC MedIQ, among others.
AI in Medical Imaging Market, Key Developments
The global AI in medical imaging market was valued at US$ 1.29 Billion in 2023. The market size reached US$ 1.58 Billion in 2024 and is expected to reach US$ 11.25 Billion by 2033, growing at a CAGR of 24.6% during the forecast period 2025-2033.
AI in Medical Imaging Market Overview
The AI in medical imaging market is rapidly advancing, fueled by the integration of deep learning algorithms into radiology workflows, enabling faster, more accurate detection of diseases such as cancer, stroke, and neurological disorders. Key drivers include increasing imaging volumes, radiologist shortages, and strong clinical validation of AI tools for triage, segmentation, and diagnosis across modalities like MRI, CT, and PET.
North America leads the market due to early regulatory approvals, robust healthcare IT infrastructure, and high adoption in hospital networks, while Asia-Pacific is the fastest-growing region, driven by aggressive digital health investments in China, Japan, and South Korea, and rising demand for scalable diagnostic solutions.
AI in Medical Imaging Market Dynamics: Drivers & Restraints
Drivers:
Rising demand for early and accurate diagnosis is significantly driving the AI in medical imaging market growth
The growing need for early and precise diagnosis is playing a crucial role in advancing the medical imaging industry, particularly in 2024 and 2025. Conditions such as cancer, stroke, and neurodegenerative diseases demand timely detection to improve treatment outcomes, pushing healthcare providers to seek faster and more accurate imaging technologies. Diagnostic tools are evolving to help clinicians manage increasing caseloads while enhancing image clarity and interpretation accuracy.
For instance, new imaging suites introduced at ECR 2025, including advanced mammography and multi-organ diagnostic platforms, are designed to streamline workflows and improve diagnostic confidence. Innovations like accelerated MRI scanning and enhanced image resolution are also helping reduce patient wait times and improve clinical decision-making.
These developments underscore the healthcare sector’s focus on improving diagnostic efficiency and accuracy to support earlier intervention and better patient outcomes.
The increasing technological advancements are expected to boost the AI in medical imaging market
Technological advancements are fueling a transformative wave in the medical imaging market by enabling significantly faster, higher-quality, and more intelligent diagnostic processes. For instance, in early 2025, Subtle Medical unveiled AI-driven MRI enhancements that accelerate scan time, enable ultra–low-dose imaging, and synthesize missing sequences.
Additionally, in May 2025, Philips, in collaboration with NVIDIA, introduced a “foundation model” for MRI at ISMRM to enhance scan planning, denoising, super-resolution, and interactive image optimization directly in clinical workflows. GE HealthCare and NVIDIA also partnered to develop autonomous X-ray and ultrasound systems, using AI-enhanced robotics to reduce operator dependency and expand diagnostic access.
Cardiovascular diagnostics have also been redefined: Avandra Imaging released an AI-powered MRI platform in 2025, delivering cardiac scan results within minutes, and India’s SGPGIMS began using an AI-enabled intravascular OCT system in May 2025, offering live, high-resolution imaging to guide precision angioplasty. Complementing hardware innovation are software breakthroughs like Viz.ai’s FDA-cleared CT-based tool for automated detection of subdural hemorrhages (June 2025). Together, these advances are reshaping medical imaging to support earlier and more precise diagnoses.
Restraint:
Data privacy and security concerns are hampering the growth of the AI in medical imaging market
Concerns around data privacy and security are anticipated to pose significant challenges to the growth of the medical imaging market, largely due to the sensitive nature of patient health information and the rising vulnerabilities within digital healthcare systems.
Modern imaging technologies often rely on vast amounts of clinical and diagnostic data for analysis, interpretation, and storage. This creates substantial risks related to compliance with strict data protection regulations such as HIPAA in the United States, GDPR in the European Union, and similar laws in other regions. The need to safeguard this information against unauthorized access, breaches, and misuse places a heavy burden on healthcare providers and technology vendors, potentially slowing down the adoption of new imaging solutions and increasing operational costs.
Opportunity:
The expansion into emerging regions is expected to create a lucrative opportunity for the AI in medical imaging market
The development of multimodal AI solutions presents a significant opportunity for the AI in medical imaging market, as it enables a more comprehensive and accurate understanding of patient health by integrating data from multiple sources. Unlike traditional imaging tools that rely solely on visual data, multimodal systems combine various types of inputs to deliver deeper diagnostic insights and personalized care recommendations.
This integrated approach improves diagnostic precision, particularly for complex conditions like cancer, cardiovascular disease, and neurological disorders, where visual findings alone may not be sufficient. For example, combining imaging with blood biomarkers and patient history can help differentiate between benign and malignant tumors more effectively or predict disease progression with higher accuracy.
AI in Medical Imaging Market Segment Analysis
The global AI in medical imaging market is segmented based on modality, deployment mode, component, and region.
The X-ray imaging from the type segment is expected to hold 26.8% of the market share in 2024 in the AI in medical imaging market
X-ray imaging is expected to dominate the AI in medical imaging market due to its widespread use, affordability, and recent technological advancements that have significantly enhanced diagnostic efficiency. As the most commonly performed imaging modality globally, X-rays provide an ideal platform for AI integration, particularly for high-volume screenings such as chest, trauma, and musculoskeletal assessments. Recent developments underscore this trend, including Gleamer’s FDA-cleared ChestView now enables automated detection of lung conditions.
In May 2025, Milvue's TechCare Trauma received FDA clearance for musculoskeletal analysis, and United Imaging’s robotic uAngio AVIVA system introduced AI-enhanced interventional imaging. These advancements, coupled with increasing regulatory approvals and clinical demand, position X-ray imaging as the leading segment driving AI adoption in the medical imaging market.
AI in Medical Imaging Market Geographical Analysis
North America is expected to dominate the global AI in medical imaging market with a 42.6% share in 2024
North America is expected to lead the global AI in medical imaging market in 2025, largely due to early clinical adoption, advanced digital infrastructure, and strong industry-regulatory collaboration. Over 66% of radiology departments in the U.S. are integrating AI tools to streamline workflows, improve diagnostic accuracy, and manage increasing imaging volumes, placing the region well ahead.
This leadership is reinforced by recent launches such as GE HealthCare’s Sonic DL MRI and Philips’ CT 5300, both unveiled at RSNA 2024, which incorporate AI for faster and more precise imaging.
The FDA’s fast-track approvals, alongside initiatives like CIVIE’s RadPod for on-demand diagnostics and Subtle Medical’s AI MRI tools, further highlight the region’s pioneering role. As the chart above illustrates, North America’s aggressive adoption pace positions it as the global benchmark for AI-driven transformation in medical imaging.
Asia-Pacific is growing at the fastest pace in the AI in medical imaging market holding 22.4% of the market share
Asia-Pacific is emerging as the fastest-growing region in the AI-powered medical imaging market, driven by urgent healthcare needs and rapid digital transformation. Robust growth is fueled by a surge in chronic disease prevalence, governmental investment in infrastructure, and supportive state policies, particularly in China and India, which are scaling AI deployments across rural and urban centers.
Innovations such as India’s Telangana-led pilot of AI in cancer screenings and regional generative-AI challenges in ophthalmology underscore a boom in multimodal imaging and screening solutions across Asia-Pacific. These concerted efforts position APAC at the forefront of next-gen, AI-driven diagnostic expansion.
AI in Medical Imaging Market Top Companies
Top companies in the AI in medical imaging market include GE HealthCare, FUJIFILM Corporation, Koninklijke Philips NV, Aidoc, Blackford Analysis, Siemens Healthineers AG, Canon Medical Systems GmbH, Qure.ai, NVIDIA Corporation, SARC MedIQ, among others.
AI in Medical Imaging Market, Key Developments
- On January 27, 2025, Royal Philips unveiled its AI-enabled CT 5300 system at the 23rd Asian Oceanian Congress of Radiology (AOCR) 2025. Alongside this launch, Philips marked a major milestone by surpassing 1,500 global installations of its helium-free 1.5T wide-bore (70 cm) MRI systems, underscoring its continued innovation and leadership in sustainable, advanced imaging solutions.
- In May 2025, Avandra Imaging released an AI-powered MRI platform, delivering cardiac scan results within minutes, and India’s SGPGIMS began using an AI-enabled intravascular OCT system.
1. MARKET INTRODUCTION AND SCOPE
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
3. MARKET HIGHLIGHTS AND STRATEGIC TAKEAWAYS
3.1. Key Trends and Future Projections
3.2. Snippet by Modality
3.3. Snippet by Deployment Mode
3.4. Snippet by Component
3.5. Snippet by Region
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Demand for Early and Accurate Diagnosis
4.1.1.2. Technological Advancements
4.1.1.3. Increased Investment and Collaborations
4.1.2. Restraints
4.1.2.1. Data Privacy and Security Concerns
4.1.2.2. High Cost of AI Solutions
4.1.2.3. Regulatory Uncertainty and Ethical Concerns
4.1.3. Opportunity
4.1.3.1. Expansion into Emerging Markets
4.1.3.2. Development of Multimodal AI Solutions
4.1.4. Impact Analysis
5. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
5.1. Market Leaders and Pioneers
5.1.1. Emerging Pioneers and Prominent Players
5.1.2. Established Leaders with the Largest Marketing Brand
5.1.3. Market Leaders with Established Products
5.2. Latest Developments and Breakthroughs
5.3. Regulatory and Reimbursement Landscape
5.3.1. North America
5.3.2. Europe
5.3.3. Asia Pacific
5.3.4. South America
5.3.5. Middle East & Africa
5.4. Porter’s Five Forces Analysis
5.5. Supply Chain Analysis
5.6. Pipeline Analysis
5.7. Patent Analysis
5.8. SWOT Analysis
5.9. Unmet Needs and Gaps
5.10. Recommended Strategies for Market Entry and Expansion
5.11. Pricing Analysis and Price Dynamics
6. AI IN MEDICAL IMAGING MARKET, BY MODALITY
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
6.1.2. Market Attractiveness Index, By Modality
6.2. X-ray Imaging*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Magnetic Resonance Imaging (MRI)
6.4. Computed Tomography (CT)
6.5. Ultrasound Imaging
6.6. Mammography
6.7. Others
7. AI IN MEDICAL IMAGING MARKET, BY DIAGNOSIS TYPE
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Diagnosis Type
7.1.2. Market Attractiveness Index, By Diagnosis Type
7.2. Cloud-Based Solutions*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. On-Premise Solutions
7.4. Hybrid Models
8. AI IN MEDICAL IMAGING MARKET, BY COMPONENT
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
8.1.2. Market Attractiveness Index, By Component
8.2. Software*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Hardware
8.4. Services
9. AI IN MEDICAL IMAGING MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.1.1. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Mode
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.6.1. U.S.
9.2.6.2. Canada
9.2.6.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Mode
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.6.1. Germany
9.3.6.2. UK
9.3.6.3. France
9.3.6.4. Spain
9.3.6.5. Italy
9.3.6.6. Rest of Europe
9.4. Asia-Pacific
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Mode
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.6.1. China
9.4.6.2. India
9.4.6.3. Japan
9.4.6.4. South Korea
9.4.6.5. Rest of Asia-Pacific
9.5. South America
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Mode
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.6.1. Brazil
9.5.6.2. Argentina
9.5.6.3. Rest of South America
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Mode
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
10. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
10.1. Competitive Overview and Key Market Players
10.1.1. Market Share Analysis and Positioning Matrix
10.1.2. Strategic Partnerships, Mergers & Acquisitions
10.1.3. Key Developments in Product Portfolios and Innovations
10.1.4. Company Benchmarking
11. COMPANY PROFILES
11.1. GE HealthCare*
11.1.1. Company Overview
11.1.2. Product Portfolio
11.1.2.1. Product Description
11.1.2.2. Product Key Performance Indicators (KPIs)
12. FINANCIAL OVERVIEW
12.1. Company Revenue
12.1.1. Geographical Revenue Shares
12.1.1.1. Revenue Forecasts
12.1.2. Key Developments
12.1.2.1. Mergers & Acquisitions
12.1.2.2. Key Product Development Activities
12.1.2.3. Regulatory Approvals, etc.
12.1.3. SWOT Analysis
12.2. FUJIFILM Corporation
12.3. Koninklijke Philips NV
12.4. Aidoc
12.5. Blackford Analysis
12.6. Siemens Healthineers AG
12.7. Canon Medical Systems GmbH
12.8. Qure.ai
12.9. NVIDIA Corporation
12.10. SARC MedIQ( LIST NOT EXHAUSTIVE)
13. ASSUMPTIONS AND RESEARCH METHODOLOGY
13.1. Data Collection Methods
13.2. Data Triangulation
13.3. Forecasting Techniques
13.4. Data Verification and Validation
14. APPENDIX
14.1. About Us and Services
14.2. Contact Us
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
3. MARKET HIGHLIGHTS AND STRATEGIC TAKEAWAYS
3.1. Key Trends and Future Projections
3.2. Snippet by Modality
3.3. Snippet by Deployment Mode
3.4. Snippet by Component
3.5. Snippet by Region
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Demand for Early and Accurate Diagnosis
4.1.1.2. Technological Advancements
4.1.1.3. Increased Investment and Collaborations
4.1.2. Restraints
4.1.2.1. Data Privacy and Security Concerns
4.1.2.2. High Cost of AI Solutions
4.1.2.3. Regulatory Uncertainty and Ethical Concerns
4.1.3. Opportunity
4.1.3.1. Expansion into Emerging Markets
4.1.3.2. Development of Multimodal AI Solutions
4.1.4. Impact Analysis
5. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
5.1. Market Leaders and Pioneers
5.1.1. Emerging Pioneers and Prominent Players
5.1.2. Established Leaders with the Largest Marketing Brand
5.1.3. Market Leaders with Established Products
5.2. Latest Developments and Breakthroughs
5.3. Regulatory and Reimbursement Landscape
5.3.1. North America
5.3.2. Europe
5.3.3. Asia Pacific
5.3.4. South America
5.3.5. Middle East & Africa
5.4. Porter’s Five Forces Analysis
5.5. Supply Chain Analysis
5.6. Pipeline Analysis
5.7. Patent Analysis
5.8. SWOT Analysis
5.9. Unmet Needs and Gaps
5.10. Recommended Strategies for Market Entry and Expansion
5.11. Pricing Analysis and Price Dynamics
6. AI IN MEDICAL IMAGING MARKET, BY MODALITY
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
6.1.2. Market Attractiveness Index, By Modality
6.2. X-ray Imaging*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Magnetic Resonance Imaging (MRI)
6.4. Computed Tomography (CT)
6.5. Ultrasound Imaging
6.6. Mammography
6.7. Others
7. AI IN MEDICAL IMAGING MARKET, BY DIAGNOSIS TYPE
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Diagnosis Type
7.1.2. Market Attractiveness Index, By Diagnosis Type
7.2. Cloud-Based Solutions*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. On-Premise Solutions
7.4. Hybrid Models
8. AI IN MEDICAL IMAGING MARKET, BY COMPONENT
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
8.1.2. Market Attractiveness Index, By Component
8.2. Software*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Hardware
8.4. Services
9. AI IN MEDICAL IMAGING MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.1.1. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Mode
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.6.1. U.S.
9.2.6.2. Canada
9.2.6.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Mode
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.6.1. Germany
9.3.6.2. UK
9.3.6.3. France
9.3.6.4. Spain
9.3.6.5. Italy
9.3.6.6. Rest of Europe
9.4. Asia-Pacific
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Mode
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.6.1. China
9.4.6.2. India
9.4.6.3. Japan
9.4.6.4. South Korea
9.4.6.5. Rest of Asia-Pacific
9.5. South America
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Mode
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.6.1. Brazil
9.5.6.2. Argentina
9.5.6.3. Rest of South America
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Deployment Mode
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
10. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
10.1. Competitive Overview and Key Market Players
10.1.1. Market Share Analysis and Positioning Matrix
10.1.2. Strategic Partnerships, Mergers & Acquisitions
10.1.3. Key Developments in Product Portfolios and Innovations
10.1.4. Company Benchmarking
11. COMPANY PROFILES
11.1. GE HealthCare*
11.1.1. Company Overview
11.1.2. Product Portfolio
11.1.2.1. Product Description
11.1.2.2. Product Key Performance Indicators (KPIs)
12. FINANCIAL OVERVIEW
12.1. Company Revenue
12.1.1. Geographical Revenue Shares
12.1.1.1. Revenue Forecasts
12.1.2. Key Developments
12.1.2.1. Mergers & Acquisitions
12.1.2.2. Key Product Development Activities
12.1.2.3. Regulatory Approvals, etc.
12.1.3. SWOT Analysis
12.2. FUJIFILM Corporation
12.3. Koninklijke Philips NV
12.4. Aidoc
12.5. Blackford Analysis
12.6. Siemens Healthineers AG
12.7. Canon Medical Systems GmbH
12.8. Qure.ai
12.9. NVIDIA Corporation
12.10. SARC MedIQ( LIST NOT EXHAUSTIVE)
13. ASSUMPTIONS AND RESEARCH METHODOLOGY
13.1. Data Collection Methods
13.2. Data Triangulation
13.3. Forecasting Techniques
13.4. Data Verification and Validation
14. APPENDIX
14.1. About Us and Services
14.2. Contact Us
LIST OF TABLES
Table 1 Global AI in Medical Imaging Market Value, By Modality, 2025, 2029 & 2033 (US$ Billion)
Table 2 Global AI in Medical Imaging Market Value, By Deployment Mode, 2025, 2029 & 2033 (US$ Billion)
Table 3 Global AI in Medical Imaging Market Value, By Component, 2025, 2029 & 2033 (US$ Billion)
Table 4 Global AI in Medical Imaging Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 5 Global AI in Medical Imaging Market Value, By Modality, 2025, 2029 & 2033 (US$ Billion)
Table 6 Global AI in Medical Imaging Market Value, By Modality, 2022-2033 (US$ Billion)
Table 7 Global AI in Medical Imaging Market Value, By Deployment Mode, 2025, 2029 & 2033 (US$ Billion)
Table 8 Global AI in Medical Imaging Market Value, By Deployment Mode, 2022-2033 (US$ Billion)
Table 9 Global AI in Medical Imaging Market Value, By Component, 2025, 2029 & 2033 (US$ Billion)
Table 10 Global AI in Medical Imaging Market Value, By Component, 2022-2033 (US$ Billion)
Table 11 Global AI in Medical Imaging Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 12 Global AI in Medical Imaging Market Value, By Region, 2022-2033 (US$ Billion)
Table 13 North America AI in Medical Imaging Market Value, By Modality, 2022-2033 (US$ Billion)
Table 14 North America AI in Medical Imaging Market Value, By Deployment Mode, 2022-2033 (US$ Billion)
Table 15 North America AI in Medical Imaging Market Value, By Component, 2022-2033 (US$ Billion)
Table 16 North America AI in Medical Imaging Market Value, By Country, 2022-2033 (US$ Billion)
Table 17 Asia-Pacific AI in Medical Imaging Market Value, By Modality, 2022-2033 (US$ Billion)
Table 18 Asia-Pacific AI in Medical Imaging Market Value, By Deployment Mode, 2022-2033 (US$ Billion)
Table 19 Asia-Pacific AI in Medical Imaging Market Value, By Component, 2022-2033 (US$ Billion)
Table 20 Asia-Pacific AI in Medical Imaging Market Value, By Country, 2022-2033 (US$ Billion)
Table 21 Europe AI in Medical Imaging Market Value, By Modality, 2022-2033 (US$ Billion)
Table 22 Europe AI in Medical Imaging Market Value, By Deployment Mode, 2022-2033 (US$ Billion)
Table 23 Europe AI in Medical Imaging Market Value, By Component, 2022-2033 (US$ Billion)
Table 24 Europe AI in Medical Imaging Market Value, By Country, 2022-2033 (US$ Billion)
Table 25 South America AI in Medical Imaging Market Value, By Modality, 2022-2033 (US$ Billion)
Table 26 South America AI in Medical Imaging Market Value, By Deployment Mode, 2022-2033 (US$ Billion)
Table 27 South America AI in Medical Imaging Market Value, By Component, 2022-2033 (US$ Billion)
Table 28 South America AI in Medical Imaging Market Value, By Country, 2022-2033 (US$ Billion)
Table 29 Middle East and Africa AI in Medical Imaging Market Value, By Modality, 2022-2033 (US$ Billion)
Table 30 Middle East and Africa AI in Medical Imaging Market Value, By Deployment Mode, 2022-2033 (US$ Billion)
Table 31 Middle East and Africa AI in Medical Imaging Market Value, By Component, 2022-2033 (US$ Billion)
Table 32 Middle East and Africa AI in Medical Imaging Market Value, By Country, 2022-2033 (US$ Billion)
Table 33 GE HealthCare: Overview
Table 34 GE HealthCare: Product Portfolio
Table 35 GE HealthCare: Key Developments
Table 36 FUJIFILM Corporation: Overview
Table 37 FUJIFILM Corporation: Product Portfolio
Table 38 FUJIFILM Corporation: Key Developments
Table 39 Koninklijke Philips NV: Overview
Table 40 Koninklijke Philips NV: Product Portfolio
Table 41 Koninklijke Philips NV: Key Developments
Table 42 Aidoc: Overview
Table 43 Aidoc: Product Portfolio
Table 44 Aidoc: Key Developments
Table 45 Blackford Analysis: Overview
Table 46 Blackford Analysis: Product Portfolio
Table 47 Blackford Analysis: Key Developments
Table 48 Siemens Healthineers AG: Overview
Table 49 Siemens Healthineers AG: Product Portfolio
Table 50 Siemens Healthineers AG: Key Developments
Table 51 Canon Medical Systems GmbH: Overview
Table 52 Canon Medical Systems GmbH: Product Portfolio
Table 53 Canon Medical Systems GmbH: Key Developments
Table 54 Qure.ai: Overview
Table 55 Qure.ai: Product Portfolio
Table 56 Qure.ai: Key Developments
Table 57 NVIDIA Corporation: Overview
Table 58 NVIDIA Corporation: Product Portfolio
Table 59 NVIDIA Corporation: Key Developments
Table 60 SARC MedIQ: Overview
Table 61 SARC MedIQ: Product Portfolio
Table 62 SARC MedIQ: Key Developments
Table 1 Global AI in Medical Imaging Market Value, By Modality, 2025, 2029 & 2033 (US$ Billion)
Table 2 Global AI in Medical Imaging Market Value, By Deployment Mode, 2025, 2029 & 2033 (US$ Billion)
Table 3 Global AI in Medical Imaging Market Value, By Component, 2025, 2029 & 2033 (US$ Billion)
Table 4 Global AI in Medical Imaging Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 5 Global AI in Medical Imaging Market Value, By Modality, 2025, 2029 & 2033 (US$ Billion)
Table 6 Global AI in Medical Imaging Market Value, By Modality, 2022-2033 (US$ Billion)
Table 7 Global AI in Medical Imaging Market Value, By Deployment Mode, 2025, 2029 & 2033 (US$ Billion)
Table 8 Global AI in Medical Imaging Market Value, By Deployment Mode, 2022-2033 (US$ Billion)
Table 9 Global AI in Medical Imaging Market Value, By Component, 2025, 2029 & 2033 (US$ Billion)
Table 10 Global AI in Medical Imaging Market Value, By Component, 2022-2033 (US$ Billion)
Table 11 Global AI in Medical Imaging Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 12 Global AI in Medical Imaging Market Value, By Region, 2022-2033 (US$ Billion)
Table 13 North America AI in Medical Imaging Market Value, By Modality, 2022-2033 (US$ Billion)
Table 14 North America AI in Medical Imaging Market Value, By Deployment Mode, 2022-2033 (US$ Billion)
Table 15 North America AI in Medical Imaging Market Value, By Component, 2022-2033 (US$ Billion)
Table 16 North America AI in Medical Imaging Market Value, By Country, 2022-2033 (US$ Billion)
Table 17 Asia-Pacific AI in Medical Imaging Market Value, By Modality, 2022-2033 (US$ Billion)
Table 18 Asia-Pacific AI in Medical Imaging Market Value, By Deployment Mode, 2022-2033 (US$ Billion)
Table 19 Asia-Pacific AI in Medical Imaging Market Value, By Component, 2022-2033 (US$ Billion)
Table 20 Asia-Pacific AI in Medical Imaging Market Value, By Country, 2022-2033 (US$ Billion)
Table 21 Europe AI in Medical Imaging Market Value, By Modality, 2022-2033 (US$ Billion)
Table 22 Europe AI in Medical Imaging Market Value, By Deployment Mode, 2022-2033 (US$ Billion)
Table 23 Europe AI in Medical Imaging Market Value, By Component, 2022-2033 (US$ Billion)
Table 24 Europe AI in Medical Imaging Market Value, By Country, 2022-2033 (US$ Billion)
Table 25 South America AI in Medical Imaging Market Value, By Modality, 2022-2033 (US$ Billion)
Table 26 South America AI in Medical Imaging Market Value, By Deployment Mode, 2022-2033 (US$ Billion)
Table 27 South America AI in Medical Imaging Market Value, By Component, 2022-2033 (US$ Billion)
Table 28 South America AI in Medical Imaging Market Value, By Country, 2022-2033 (US$ Billion)
Table 29 Middle East and Africa AI in Medical Imaging Market Value, By Modality, 2022-2033 (US$ Billion)
Table 30 Middle East and Africa AI in Medical Imaging Market Value, By Deployment Mode, 2022-2033 (US$ Billion)
Table 31 Middle East and Africa AI in Medical Imaging Market Value, By Component, 2022-2033 (US$ Billion)
Table 32 Middle East and Africa AI in Medical Imaging Market Value, By Country, 2022-2033 (US$ Billion)
Table 33 GE HealthCare: Overview
Table 34 GE HealthCare: Product Portfolio
Table 35 GE HealthCare: Key Developments
Table 36 FUJIFILM Corporation: Overview
Table 37 FUJIFILM Corporation: Product Portfolio
Table 38 FUJIFILM Corporation: Key Developments
Table 39 Koninklijke Philips NV: Overview
Table 40 Koninklijke Philips NV: Product Portfolio
Table 41 Koninklijke Philips NV: Key Developments
Table 42 Aidoc: Overview
Table 43 Aidoc: Product Portfolio
Table 44 Aidoc: Key Developments
Table 45 Blackford Analysis: Overview
Table 46 Blackford Analysis: Product Portfolio
Table 47 Blackford Analysis: Key Developments
Table 48 Siemens Healthineers AG: Overview
Table 49 Siemens Healthineers AG: Product Portfolio
Table 50 Siemens Healthineers AG: Key Developments
Table 51 Canon Medical Systems GmbH: Overview
Table 52 Canon Medical Systems GmbH: Product Portfolio
Table 53 Canon Medical Systems GmbH: Key Developments
Table 54 Qure.ai: Overview
Table 55 Qure.ai: Product Portfolio
Table 56 Qure.ai: Key Developments
Table 57 NVIDIA Corporation: Overview
Table 58 NVIDIA Corporation: Product Portfolio
Table 59 NVIDIA Corporation: Key Developments
Table 60 SARC MedIQ: Overview
Table 61 SARC MedIQ: Product Portfolio
Table 62 SARC MedIQ: Key Developments
LIST OF FIGURES
Figure 1 Global AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 2 Global AI in Medical Imaging Market Share, By Modality, 2024 & 2033 (%)
Figure 3 Global AI in Medical Imaging Market Share, By Deployment Mode, 2024 & 2033 (%)
Figure 4 Global AI in Medical Imaging Market Share, By Component, 2024 & 2033 (%)
Figure 5 Global AI in Medical Imaging Market Share, By Region, 2024 & 2033 (%)
Figure 6 Global AI in Medical Imaging Market Y-o-Y Growth, By Modality, 2023-2033 (%)
Figure 7 X-ray Imaging AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 8 Magnetic Resonance Imaging (MRI) AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 9 Computed Tomography (CT) AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 10 Ultrasound Imaging AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 11 Mammography AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 12 Others AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 13 Global AI in Medical Imaging Market Y-o-Y Growth, By Deployment Mode, 2023-2033 (%)
Figure 14 Cloud-Based Solutions Deployment Mode in Global AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 15 On-Premise Solutions Deployment Mode in Global AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 16 Hybrid Models Deployment Mode in Global AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 17 Global AI in Medical Imaging Market Y-o-Y Growth, By Component, 2023-2033 (%)
Figure 18 Software Component in Global AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 19 Hardware Component in Global AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 20 Services Component in Global AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 21 Global AI in Medical Imaging Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 22 North America AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 23 North America AI in Medical Imaging Market Share, By Modality, 2024 & 2033 (%)
Figure 24 North America AI in Medical Imaging Market Share, By Deployment Mode, 2024 & 2033 (%)
Figure 25 North America AI in Medical Imaging Market Share, By Component, 2024 & 2033 (%)
Figure 26 North America AI in Medical Imaging Market Share, By Country, 2024 & 2033 (%)
Figure 27 Asia-Pacific AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 28 Asia-Pacific AI in Medical Imaging Market Share, By Modality, 2024 & 2033 (%)
Figure 29 Asia-Pacific AI in Medical Imaging Market Share, By Deployment Mode, 2024 & 2033 (%)
Figure 30 Asia-Pacific AI in Medical Imaging Market Share, By Component, 2024 & 2033 (%)
Figure 31 Asia-Pacific AI in Medical Imaging Market Share, By Country, 2024 & 2033 (%)
Figure 32 Europe AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 33 Europe AI in Medical Imaging Market Share, By Modality, 2024 & 2033 (%)
Figure 34 Europe AI in Medical Imaging Market Share, By Deployment Mode, 2024 & 2033 (%)
Figure 35 Europe AI in Medical Imaging Market Share, By Component, 2024 & 2033 (%)
Figure 36 Europe AI in Medical Imaging Market Share, By Country, 2024 & 2033 (%)
Figure 37 South America AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 38 South America AI in Medical Imaging Market Share, By Modality, 2024 & 2033 (%)
Figure 39 South America AI in Medical Imaging Market Share, By Deployment Mode, 2024 & 2033 (%)
Figure 40 South America AI in Medical Imaging Market Share, By Component, 2024 & 2033 (%)
Figure 41 South America AI in Medical Imaging Market Share, By Country, 2024 & 2033 (%)
Figure 42 Middle East and Africa AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 43 Middle East and Africa AI in Medical Imaging Market Share, By Modality, 2024 & 2033 (%)
Figure 44 Middle East and Africa AI in Medical Imaging Market Share, By Deployment Mode, 2024 & 2033 (%)
Figure 45 Middle East and Africa AI in Medical Imaging Market Share, By Component, 2024 & 2033 (%)
Figure 46 GE HealthCare: Financials
Figure 47 FUJIFILM Corporation: Financials
Figure 48 Koninklijke Philips NV: Financials
Figure 49 Aidoc: Financials
Figure 50 Blackford Analysis: Financials
Figure 51 Siemens Healthineers AG: Financials
Figure 52 Canon Medical Systems GmbH: Financials
Figure 53 Qure.ai: Financials
Figure 54 NVIDIA Corporation: Financials
Figure 55 SARC MedIQ: Financials
Figure 1 Global AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 2 Global AI in Medical Imaging Market Share, By Modality, 2024 & 2033 (%)
Figure 3 Global AI in Medical Imaging Market Share, By Deployment Mode, 2024 & 2033 (%)
Figure 4 Global AI in Medical Imaging Market Share, By Component, 2024 & 2033 (%)
Figure 5 Global AI in Medical Imaging Market Share, By Region, 2024 & 2033 (%)
Figure 6 Global AI in Medical Imaging Market Y-o-Y Growth, By Modality, 2023-2033 (%)
Figure 7 X-ray Imaging AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 8 Magnetic Resonance Imaging (MRI) AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 9 Computed Tomography (CT) AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 10 Ultrasound Imaging AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 11 Mammography AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 12 Others AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 13 Global AI in Medical Imaging Market Y-o-Y Growth, By Deployment Mode, 2023-2033 (%)
Figure 14 Cloud-Based Solutions Deployment Mode in Global AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 15 On-Premise Solutions Deployment Mode in Global AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 16 Hybrid Models Deployment Mode in Global AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 17 Global AI in Medical Imaging Market Y-o-Y Growth, By Component, 2023-2033 (%)
Figure 18 Software Component in Global AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 19 Hardware Component in Global AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 20 Services Component in Global AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 21 Global AI in Medical Imaging Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 22 North America AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 23 North America AI in Medical Imaging Market Share, By Modality, 2024 & 2033 (%)
Figure 24 North America AI in Medical Imaging Market Share, By Deployment Mode, 2024 & 2033 (%)
Figure 25 North America AI in Medical Imaging Market Share, By Component, 2024 & 2033 (%)
Figure 26 North America AI in Medical Imaging Market Share, By Country, 2024 & 2033 (%)
Figure 27 Asia-Pacific AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 28 Asia-Pacific AI in Medical Imaging Market Share, By Modality, 2024 & 2033 (%)
Figure 29 Asia-Pacific AI in Medical Imaging Market Share, By Deployment Mode, 2024 & 2033 (%)
Figure 30 Asia-Pacific AI in Medical Imaging Market Share, By Component, 2024 & 2033 (%)
Figure 31 Asia-Pacific AI in Medical Imaging Market Share, By Country, 2024 & 2033 (%)
Figure 32 Europe AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 33 Europe AI in Medical Imaging Market Share, By Modality, 2024 & 2033 (%)
Figure 34 Europe AI in Medical Imaging Market Share, By Deployment Mode, 2024 & 2033 (%)
Figure 35 Europe AI in Medical Imaging Market Share, By Component, 2024 & 2033 (%)
Figure 36 Europe AI in Medical Imaging Market Share, By Country, 2024 & 2033 (%)
Figure 37 South America AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 38 South America AI in Medical Imaging Market Share, By Modality, 2024 & 2033 (%)
Figure 39 South America AI in Medical Imaging Market Share, By Deployment Mode, 2024 & 2033 (%)
Figure 40 South America AI in Medical Imaging Market Share, By Component, 2024 & 2033 (%)
Figure 41 South America AI in Medical Imaging Market Share, By Country, 2024 & 2033 (%)
Figure 42 Middle East and Africa AI in Medical Imaging Market Value, 2022-2033 (US$ Billion)
Figure 43 Middle East and Africa AI in Medical Imaging Market Share, By Modality, 2024 & 2033 (%)
Figure 44 Middle East and Africa AI in Medical Imaging Market Share, By Deployment Mode, 2024 & 2033 (%)
Figure 45 Middle East and Africa AI in Medical Imaging Market Share, By Component, 2024 & 2033 (%)
Figure 46 GE HealthCare: Financials
Figure 47 FUJIFILM Corporation: Financials
Figure 48 Koninklijke Philips NV: Financials
Figure 49 Aidoc: Financials
Figure 50 Blackford Analysis: Financials
Figure 51 Siemens Healthineers AG: Financials
Figure 52 Canon Medical Systems GmbH: Financials
Figure 53 Qure.ai: Financials
Figure 54 NVIDIA Corporation: Financials
Figure 55 SARC MedIQ: Financials
